Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Thomas Kuehne"'
Autor:
Alix Catherine O'Meara, Andreas Holbro, Sara Meyer, Maria Martinez, Michael Medinger, Andreas Buser, Joerg Halter, Dominik Heim, Sabine Gerull, Christoph Bucher, Alicia Rovo, Thomas Kuehne, André Tichelli, Alois Gratwohl, Martin Stern, Jakob Passweg
Publikováno v:
Swiss Medical Weekly, Vol 144, Iss 0910 (2014)
The purpose of this study was to examine changes in haematopoietic stem cell transplant (HSCT) characteristics and outcome in our combined paediatric and adult programme over the past four decades, since its implementation in 1973. The total number o
Externí odkaz:
https://doaj.org/article/f5e1076a86f142c284d4ec66fab26309
This open access book brings together contributions from an internationally diverse group of scholars to celebrate Taner Akçam's role as the first Turkish intellectual to publicly recognize the Armenian Genocide. As a researcher, lecturer, and ment
Long-Term Outcome of Adolescents and Young Adults with Chronic Primary Immune Thrombocytopenia (ITP)
Autor:
Alexandra Schifferli, Gautier Le Gavrian, Nathalie Aladjidi, Guillaume Moulis, Bertrand Godeau, Thierry Leblanc, Marc Michel, Guy Leverger, Helder Fernandes, Thomas Kuehne
Publikováno v:
Blood. 140:5551-5552
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d9e393ecc4b5bf5d83edd3c2bdb064c
https://doi.org/10.1182/blood-2022-169194
https://doi.org/10.1182/blood-2022-169194
Autor:
Thomas Kuehne
Publikováno v:
The American Historical Review. 127:1040-1041
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84badca234e3ae4677ce8286a69192e0
https://doi.org/10.1093/ahr/rhab611
https://doi.org/10.1093/ahr/rhab611
Autor:
Martin McCabe, Laura Kirton, Maria Khan, Nicola Fenwick, Sandra J. Strauss, Claudia Valverde, Cristina Mata, Nathalie Gaspar, Roberto Luksch, Alessandra Longhi, Uta Dirksen, Marianne Phillips, Akmal Safwat, Hans Gelderblom, Thomas Kuehne, Jukka Kanerva, Andrew J. Westwood, Stefano Ferrari, Jeremy Whelan, Keith Wheatley
Publikováno v:
Journal of Clinical Oncology. 40:LBA2-LBA2
LBA2 Background: 5-year survival of RR-ES is about 15%. rEECur, the first randomized controlled trial in this setting, is defining standard care, balancing efficacy and toxicity. Methods: Patients aged 4-50 with RR-ES were randomly assigned to topote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f657619fa7ccfa22cc6e36b3732119ab
https://doi.org/10.1200/jco.2022.40.17_suppl.lba2
https://doi.org/10.1200/jco.2022.40.17_suppl.lba2
Autor:
Thomas Kuehne, Ruth Ladenstein, Uta Dirksen, Bénédicte Brichard, Jarmila Kruseova, Dimosthenis Andreou, Heribert Juergens, Hans Gelderblom, Attila Kollár, Per-Ulf Tunn, Andreas Ranft, Hans-Theodor Eich, Jendrik Hardes, Arne Streitbuerger, Wolfgang Hartmann, Daniel Baumhoer, Beate Timmermann, Andreas Leithner, Henk van den Berg
11502 Background: Outcome in EwS has improved by the implementation of dose or time intense systemic treatment. Aim of the study was evaluate whether treatment delays have impact on outcome of patients with localized Ewing sarcoma (EWS). Methods: Dat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b98444fb42479c4b8f9e57bf4d9f535a
Autor:
Thomas Kuehne, C Atkinson
Multi-Level Modeling is receiving increasing levels of interest and its active research community is continuing to make progress. However, to advance the discipline effectively it is necessary to increase industry adoption and achieve better communit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ca8e7ca738ec4e2de6836d09db5c8f9
https://doi.org/10.26686/wgtn.13224761.v1
https://doi.org/10.26686/wgtn.13224761.v1
Autor:
Thomas Kuehne
© 2018 CEUR-WS. All rights reserved. Despite being one of the fundamental concepts of multi-level modeling - to the extent of occurring in the name of the discipline - the concept of “level” has no universally agreed upon meaning among multi-lev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5eb8fda92389c7aa48162b5f5a37e86e
https://doi.org/10.26686/wgtn.13224752.v1
https://doi.org/10.26686/wgtn.13224752.v1
Autor:
Thomas Kühne
The material of ITP became more and more complex and substantial in recent years. The current edition was updated in a difficult time reflected by the COVID-19 pandemic with many obstacles and adversities. Therefore all authors worked hard on this ed
Autor:
Thomas Kuehne, Heike Faeth, Andreas Holbro, Axel Rüfer, Renata Rosa Pereira, Nathan Cantoni, Geneviève Favre, Anna Wieland, Falk Nimmerjahn, Alexandra Schifferli, Alicia Rovó, Jan Dirks
Publikováno v:
Blood. 138:3149-3149
Introduction : To date most treatment strategies of primary immune thrombocytopenia (ITP) are symptomatic, preventing premature platelet destruction and increasing their production. New strategies should focus on targeting the immune dysregulation, r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::82389514c5b451418b3c12116d971b87
https://doi.org/10.1182/blood-2021-146648
https://doi.org/10.1182/blood-2021-146648